Table. 2.

Demographics, tumor characteristics, and treatment by income group

Intrahepatic tumor Perihilar tumor Distal tumor



Overall Low income High income p-value Overall Low income High income p-value Overall Low income High income p-value
Number 2,867 685 2,182 1,968 515 1,453 641 172 469
Age (yr) 68.33 ± 12.14 68.87 ± 12.10 68.17 ± 12.16 0.186 71.47 ± 11.90 71.33 ± 12.12 71.52 ± 11.82 0.749 71.90 ± 11.33 71.70 ± 11.28 71.97 ± 11.36 0.794
Male sex 1,466 (51.1) 335 (48.9) 1,131 (51.8) 0.196 1,047 (53.2) 264 (51.3) 783 (53.9) 0.33 351 (54.8) 92 (53.5) 259 (55.2) 0.763
Year of diagnosis 0.005 0.006 0.206
2004–2007 664 (23.2) 183 (26.7) 481 (22.0) 812 (41.3) 228 (44.3) 584 (40.2) 6 (0.9) 0 (0) 6 (1.3)
2008–2011 931 (32.5) 232 (33.9) 699 (32.0) 638 (32.4) 179 (34.8) 459 (31.6) 207 (32.3) 51 (29.7) 156 (33.3)
2012–2015 1,272 (44.4) 270 (39.4) 1,002 (45.9) 518 (26.3) 108 (21.0) 410 (28.2) 428 (66.8) 121 (70.3) 307 (65.5)
Race < 0.001 < 0.001 < 0.001
American Indian/Alaska Native 40 (1.4) 33 (4.8) 7 (0.3) 22 (1.1) 17 (3.3) 5 (0.3) 17 (2.7) 12 (7.0) 5 (1.1)
Asian or Pacific Islander 482 (16.8) 37 (5.4) 445 (20.4) 321 (16.3) 23 (4.5) 298 (20.5) 97 (15.1) 10 (5.8) 87 (18.6)
Black 191 (6.7) 65 (9.5) 126 (5.8) 150 (7.6) 67 (13.0) 83 (5.7) 33 (5.1) 15 (8.7) 18 (3.8)
Unknown 7 (0.2) 0 (0) 7 (0.3) 2 (0.1) 0 (0) 2 (0.1) 3 (0.5) 0 (0) 3 (0.6)
White 2,147 (74.9) 550 (80.3) 1,597 (73.2) 1,473 (74.8) 408 (79.2) 1,065 (73.3) 491 (76.6) 135 (78.5) 356 (75.9)
Tumor gradea) 0.253 0.062 0.163
Well differentiated (Grade 1) 98 (9.8) 12 (6.2) 86 (10.7) 89 (14.5) 21 (14.9) 68 (14.3) 33 (12.3) 12 (19.0) 21 (10.2)
Moderately differentiated (Grade 2) 455 (45.7) 92 (47.4) 363 (45.3) 272 (44.2) 71 (50.4) 201 (42.4) 119 (44.4) 30 (47.6) 89 (43.4)
Poorly differentiated (Grade 3) 424 (42.6) 85 (43.8) 339 (42.3) 239 (38.9) 43 (30.5) 196 (41.4) 111 (41.4) 20 (31.7) 91 (44.4)
Undifferentiated/anaplastic (Grade 4) 19 (1.9) 5 (2.6) 14 (1.7) 15 (2.4) 6 (4.3) 9 (1.9) 5 (1.9) 1 (1.6) 4 (2.0)
Tumor stageb) 0.602 0.373 0.446
Stage 1 511 (23.1) 117 (24.6) 394 (22.7) 397 (25.8) 103 (27.4) 294 (25.3) 153 (28.1) 45 (32.6) 108 (26.5)
Stage 2 181 (8.2) 33 (6.9) 148 (8.5) 431 (28.0) 92 (24.5) 339 (29.1) 169 (31.0) 38 (27.5) 131 (32.2)
Stage 3 540 (24.4) 118 (24.8) 422 (24.3) 160 (10.4) 41 (10.9) 119 (10.2) 72 (13.2) 20 (14.5) 52 (12.8)
Stage 4 980 (44.3) 207 (43.6) 773 (44.5) 551 (35.8) 140 (37.2) 411 (35.3) 151 (27.7) 35 (25.4) 116 (28.5)
Tumor size (mm) 67.35 ± 49.60 69.14 ± 69.61 66.89 ± 42.95 0.465 33.48 ± 39.31 38.85 ± 66.28 31.64 ± 23.82 0.028 29.59 ± 53.02 25.52 ± 17.03 30.99 ± 60.61 0.4
Treatment < 0.001 0.209 0.202
Surgery 442 (15.4) 87 (12.7) 355 (16.3) 423 (21.5) 100 (19.4) 323 (22.2) 220 (34.3) 57 (33.1) 163 (34.8)
No surgery 2,244 (78.3) 541 (79.0) 1,703 (78.0) 1,505 (76.5) 400 (77.7) 1,105 (76.0) 419 (65.4) 114 (66.3) 305 (65.0)
Local tumor destruction 60 (2.1) 7 (1.0) 53 (2.4) 7 (0.4) 2 (0.4) 5 (0.3) 0 (0) 0 (0) 0 (0)
Treatment unknown 121 (4.2) 50 (7.3) 71 (3.3) 33 (1.7) 13 (2.5) 20 (1.4) 2 (0.3) 1 (0.6) 1 (0.2)
No radiation or unknown radiation therapy 2,508 (87.5) 598 (87.3) 1,910 (87.5) 0.923 1,619 (82.3) 421 (81.7) 1,198 (82.5) 0.771 510 (79.6) 137 (79.7) 373 (79.5) > 0.999
Received chemotherapy 1,203 (42.0) 251 (36.6) 952 (43.6) 0.001 678 (34.5) 160 (31.1) 518 (35.7) 0.068 255 (39.8) 57 (33.1) 198 (42.2) 0.047
% Bachelor’s degree 34.62 ± 10.93 22.31 ± 6.40 38.48 ± 9.04 < 0.001 34.56 ± 11.35 22.08 ± 5.70 38.99 ± 9.38 < 0.001 33.30 ± 10.30 22.27 (5.08) 37.35 (8.64) < 0.001
% Unemployed 7.90 ± 2.71 9.57 ± 4.29 7.37 ± 1.66 < 0.001 8.24 ± 2.87 10.31 ± 4.32 7.51 ± 1.59 < 0.001 8.53 ± 2.89 10.96 (3.98) 7.64 (1.65) < 0.001
Median household income (ten thousands) 6,540.60 ± 1,566.63 4,393.97 ± 555.74 7,213.51 ± 1,108.68 < 0.001 6,475.92 ± 1,622.87 4,359.74 ± 503.71 7,225.98 ± 1,151.82 < 0.001 6,316.97 ± 1,594.17 4,293.19 ± 540.46 7,059.17 ± 1,145.15 < 0.001
% Current smoking 18.09 ± 4.99 23.10 ± 2.81 16.51 ± 4.47 < 0.001 18.18 ± 5.15 23.08 ± 2.61 16.44 ± 4.69 < 0.001 18.96 ± 4.93 22.77 (2.70) 17.56 (4.82) < 0.001

Values are presented as number only, mean ± standard deviation, or number (%).

a)Only patients with complete tumor grade information were included (n = 996).

b)Only patients with complete tumor stage information were included (n = 2,212).

Ann Hepatobiliary Pancreat Surg 2024;28:144-54 https://doi.org/10.14701/ahbps.23-136
© 2024 Ann Hepatobiliary Pancreat Surg